Revolutionizing Diagnostics and Quantum Technology: Archer Materials Limited’s Breakthrough in Commercial-Scale Production of Advanced Biochips
Archer Materials Limited, an Australian semiconductor company specializing in quantum technology and medical diagnostics, has recently announced a major breakthrough. The company successfully fabricated its advanced Biochip graphene field effect transistor (gFET) design on a six-inch wafer, marking a significant milestone in transitioning from research to commercial-scale production.
This achievement was the result of a collaboration with Graphenea, a Spanish partner, and saw the production of 145 chips, each containing 8 gFET devices. The devices demonstrated the expected electronic performance and device stability, indicating a successful production run. This accomplishment showcases Archer’s commitment to enhancing its Biochip technology, with plans to develop further miniaturized designs currently in progress.
Investors looking for more information on AU:AXE stock can visit TipRanks’ Stock Analysis page for additional insights and analysis. Archer Materials Limited continues to make strides in the semiconductor industry, solidifying its position as a leader in quantum technology and medical diagnostics.
